Addiction psychology

About 1 in 7 Americans suffer from active addiction to a particular substance.[1] Addiction can cause physical, psychological, and emotional harm to those who are affected by it.[2] The American Society of Addiction Medicine defines addiction as "a treatable, chronic medical disease involving complex interactions among brain circuits, genetics, the environment, and an individual's life experiences. People with addiction use substances or engage in behaviors that become compulsive and often continue despite harmful consequences."[3] In the world of psychology and medicine, there are two models that are commonly used in understanding the psychology behind addiction itself. One model is referred to as the disease model of addiction.[4] The disease model suggests that addiction is a diagnosable disease similar to cancer or diabetes. This model attributes addiction to a chemical imbalance in an individual's brain that could be caused by genetics or environmental factors.[5] The second model is the choice model of addiction, which holds that addiction is a result of voluntary actions rather than some dysfunction of the brain.[6] Through this model, addiction is viewed as a choice and is studied through components of the brain such as reward, stress, and memory.[7] Substance addictions relate to drugs, alcohol, and smoking.[8] Process addictions relate to non-substance-related behaviors such as gambling, spending money, sexual activity, gaming, spending time on the internet, and eating.[9]

Psychologists' oldest definition of addiction is that the addict has a lack of self-control from something that has a rewarding effect which keeps them coming back. The addicted party wants to abstain, but they can't resist the temptation. Some addicts experience what they consider to be a loss of control over their actions. This can involve an internal battle between fueling the addiction and the desire to abstain and regain control.[10]

History

The word addiction has been traced to the 17th century.[11] The consumption of addictive substances, such as alcohol, opioids, and cocaine has been traced back to ancient history of Syria, China, and South America.[12] During this time period, addiction was defined as being compelled to act out any number of bad habits. Persons abusing narcotics were called opium and morphine "eaters", and the term drunkard referred to abusers of alcohol. Medical textbooks categorized these "bad habits" as dipsomania or alcoholism[13] However, it wasn't until the 19th century when the diagnosis of addiction was first printed in medical literature. In the 1880s, Sigmund Freud and William Halsted began experimenting with users of cocaine. Freud in particular was convinced that cocaine could be the answer to many mental and physical problems and published a paper "On Coca" about its benefits.[14] Being unaware of the drug's powerful addictive qualities, Freud began to commend it as a means to overcome morphine addictions. Over time, Freud and Halsted inadvertently became guinea pigs in their own research and, as a result, their contributions to psychology and medicine changed the world. Freud publicly endorsed cocaine and its uses, theorizing that cocaine could be used as an anesthetic. This idea was later tested and found to be true.[14] However, most of his other claims about cocaine turned out to be false and his advocacy for cocaine severely hurt his career.

Cocaine took possession over Freud's life while he was working in Austria's Vienna General Hospital and found that the drug relieved his migraine. When the effect of cocaine decreased, the amount of cocaine Freud consumed increased. With information about the pain suppressing properties of cocaine, physicians began prescribing cocaine to their patients who required pain relief.[13]

Unaware of Freud and Halsted's experiments with cocaine, American Physician W.H. Bentley was conducting his own similar experiments. The Index Medicus published his article describing how he successfully treated patients with cocaine who were addicted to opium and alcohol. In the late 1800s, the use of cocaine as a recreational drug spread like a worldwide epidemic.[13] It wasn't long until it was realized that cocaine was far more addictive than previously realized and how many deaths were being caused because of cocaine overdose.[14]

As cocaine continued to spread, physicians began looking for ways to treat patients with opium, cocaine, and alcohol addictions. Physicians debated the existence of the label "addictive personality," but believed the qualities Freud possessed (bold risk taking, emotional scar tissue, and psychic turmoil) were of those that fostered the "addictive personality".[13]

Important contributors

Physician Sigmund Freud, born on May 6, 1856, in Freiberg, France (an area now known as Pribor in the Czech Republic), was instrumental in the field of psychology. Dream interpretation and psychoanalysis, also known as talk therapy, are two of his well-known contributions. Psychoanalysis is used to treat a multitude of conditions including addictions.[15] As one of the most influential thinkers in the 20th century, he altered the way we perceive ourselves and communicate about our perceptions; as a number of his theories have been popularized and terms he created have entered into general language.[16]

Theories on mental health, personality development, and illness that Freud developed, are considered highly controversial. According to Freud, people are endowed with three levels of awareness: conscious, preconscious, and unconscious. The conscious level refers to what we are fully appreciative of; the preconscious, to what people could be aware of if they became more attentive; and the unconscious level includes facts that humans cannot be aware of. The aim of the therapy is to turn unconscious into conscious.[16]

William Halsted, born on September 23, 1852, in New York City, received his degree in medicine in 1877. Throughout his medical career as a surgeon, he contributed surgical techniques that ultimately led to improvement of the patient's outcome following surgery. During Halsted's professional career, he and Freud conducted experiments with the drug cocaine. While their research was in process, they became guinea pigs for their own experiments when they became addicted to cocaine. In 1884, he became the first to describe how cocaine could be utilized as a localized anesthetic when injecting into the trunk of a sensory nerve, and how the localized ischemia prolonged the anesthetic properties of the drug.[13][17]

G. Alan Marlatt was a pioneer in the field of addiction psychology. Born in Vancouver, British Columbia, in 1941, he spent his professional career as an addiction psychologist, researcher, and director of the University of Washington's Addictive Behaviors Research Center and professor in the Department of Psychology. Marlatt adopted the theory of harm reduction, and developed and scientifically tested ways to prevent an addict's slip from becoming a relapse. He understood that expecting immediate and complete abstinence from addicts often deterred addicts from seeking the help they needed and deserved.[18][19][20]

A. Thomas McLellan was born in 1949 in Staten Island, New York. He is a professor at the University of Pennsylvania School of Medicine at the Center for Studies of Addiction. McLellan serves or has served on editorial boards as a reviewer of medical and scientific journals, and as an advisor to government and non-profit organizations including: the National Practice Laboratory of the American Psychiatric Association, and the World Health Organization. He is co-founder and chief executive officer of the Treatment Research Institute located in Philadelphia, Pennsylvania. McLellan has conducted decades of research for the efficacy of treatment for substance abuse patients, and is recognized both at the national and international level as an addiction psychologist. He is also known for the development of the Addiction Severity Index or ASI and serves as editor-in-chief of the Journal of Substance Abuse Treatment, and the deputy officer of National Drug Control Policy, Research and Evaluation.[21]

Arnold Washton has specialized in addiction since 1975 and is an addiction psychologist known for his work in the development of therapeutic approaches to the treatment of drug and alcohol abuse. He is the author of many books and professional journal articles on treatment and addiction. He is a lecturer, clinician, researcher, and has served on the advisory committee for the US Food and Drug Administration. Washton is the founder and executive director of Recovery Options: a private addiction treatment practice located in New York City and Princeton, New Jersey.[22]

William L. White[23] is a Senior Research Consultant at Chestnut Health Systems, an addiction counselor, researcher, and writer in the field of addiction for over 45 years. He wrote over 400 papers and 18 books. He received awards from the National Association of Addiction Treatment Providers (NAATP), the National Council on Alcoholism and Drug Dependence, (NAADAC), the Association of Addiction Professionals, and the American Society of Addiction Medicine (ASAM).[24]

Addiction

Addiction is a progressive psychiatric disorder that is defined by the American Society of Addiction Medicine as "a primary, chronic disease of brain reward, motivation, memory and related circuitry." It is characterized by the inability to control behavior, it creates a dysfunctional emotional response, and it affects the users ability to abstain from the substance or behavior consistently."[25] Psychology Today defines addiction as "a state that can occur when a person either consumes a substance such as nicotine, cocaine, or, alcohol or engages in an activity such as gambling or shopping/spending."[26]

Many functions of the brain work to prevent addictive behaviors. Such obstacles include anxiousness about trying a drug or behavior or nervousness of the possibility of getting caught, etc.[27] Not all use of addictive substances or behavior results in addiction. However, a non-addict may choose to engage in a behavior or ingest a substance because of the pleasure the non-addict receives. A non-addict can become an addict through frequency, when an addictive behavior becomes a compulsive action. The change from non-addict to addict occurs largely from the effects of prolonged substance use and the result of behavior activities on brain functioning. Addiction affects the brain circuits of reward and motivation, learning and memory, and the inhibitory control over behavior.[28]

There are different schools of thought regarding the terms dependence and addiction when referring to drugs and behaviors. One adopted belief is that "drug dependence" equals "addiction." The second belief is that the two terms do not equal each other. According to the DSM, the clinical criteria for "drug dependence" (or what we refer to as addiction), include compulsive drug use despite harmful consequences, inability to stop using a drug, failure to meet work, social, or family obligations, and sometimes (depending on the drug), tolerance and withdrawal.

The latter reflects physical dependence in which the body adapts to the drug, requiring more of it to achieve a certain effect (tolerance)[29] and eliciting drug-specific physical or mental symptoms if drug use is abruptly ceased (withdrawal). Physical dependence can happen with the chronic use of many drugs—including even appropriate, medically instructed use. Thus, physical dependence in and of itself does not constitute addiction, but often accompanies addiction. This distinction can be difficult to discern, particularly with prescribed pain medications, where the need for increasing dosages can represent tolerance or a worsening underlying problem, as opposed to the beginning of abuse or addiction.

There are some characteristics of addiction, that regardless of the type, share commonalities. The behavior provides a rapid and potent means of altering mood, thoughts, and sensations of a person, which occur because of physiology and learned expectations. The immediate precipitating factors of the relapse, the timing of the relapse and the rate of relapse following treatment is high.

American Psychological Association

The American Psychological Association (APA) is a professional psychological organization and is the largest association of psychologists in the United States. Over 100,000 researchers, educators, clinicians, and students support the association through their membership. Their mission "is to advance the creation, communication and application of psychological knowledge to benefit society and improve people's lives."[30]

APA supports 54 divisions, two of which pertain to addictions. Division 50, Society of Addiction Psychology promotes advances in research, professional training, and clinical practice within the range of addictive behaviors. Addictive behaviors include problematic use of alcohol, nicotine, and other drugs as well as disorders involving gambling, eating, spending, and sexual behavior.[31] Division 28, Psychopharmacology and Substance Abuse promotes teaching, research, and dissemination of information regarding the effects of drugs on behavior.[32]

The College of Professional Psychology (CPP), hosted by the American Psychological Association Practice Organization, previously offered a certificate to psychologists whom demonstrated proficiency in the psychological treatment of alcohol and other substance-related disorders. The CPP maintains the certificate of proficiency for persons who acquired it prior to 2011. The Society of Addiction Psychology certificate will be re-instated while the Society examines other avenues for credentialing professionals in addiction treatment.[33]

Addiction as a disease

Addiction can express itself in numerous different ways and look different in every person that is affected by it. Over the course of many years, researchers and scientists have tried to pinpoint the cause of addiction. This has led to many different theories and explanations for what causes individuals to become relentlessly dependent on drugs, alcohol, or other addictive substances. A few of these theories include, the disease model, the choice model, genetic contributions, the reward effect, and other environmental factors.[34] Each of these theories will be explained and discuss the limitations of each below.

Disease model in addiction

According to the new disease model, rather than being a disease in the conventional sense, addiction is a disease of choice. That is, it is a disorder of the parts of the brain necessary to make proper decisions. As one becomes addicted to cocaine, the ventral tegmentum nucleus accumbens in the brain is the organ.[7] The defect is stress-induced hedonic regulation.

Understanding the impact that genes, reward, memory, stress, and choice have on an individual will begin to explain the Disease Model of Addiction

Genetic

Studies have proven that genetic variations and differences in our neurobiology can alter an individual's vulnerability to developing an addiction.[35] Estimates have shown that around 40%-60% of the susceptibility of an individual to develop an addiction to drugs, nicotine, and alcohol is allotted to genetic variables.[35] The genetic makeup of an individual determines how they respond to alcohol. What causes an individual to be more prone to addiction is their genetic makeup. For example, there are genetic differences in how people respond to methylphenidate (Ritalin) injections.[36]

Reward

One of the earliest theories of addiction was the reward effect. This theory suggests that an individual consumes a substance that will elicit a pleasurable effect. The individual continues to use this substance to recreate this same feeling, ultimately becoming addicted to the sensation they receive from the substance.[37] The idea of positive reinforcement has been used to explain why individuals become increasingly dependent on a particular substance. An issue with this theory is that most addictive drugs cause an individual to build up a tolerance and the effects of the drug will decrease as an individual's tolerance increases. This requires individuals to use a higher dosage of the substance which in many causes can cause adverse side effects.[37] Dopamine is correlated with increased pleasure. For that reason, dopamine plays a significant role in reinforcing experiences. It tells the brain the drug is better than expected. When an individual uses a drug, there may be a surge of dopamine in the midbrain, which can result in the shifting of that individual's pleasure "threshold" (see figures one and two).[7]

Memory

The neurochemical, glutamate, is the most abundant neurochemical in the brain; it is critical in memory consolidation. When an addict discovers an addicting behavior, glutamate plays a role by creating the drug cues. It is the neurochemical in motivation which initiates the drug seeking, thus creating the addiction.[38]

Stress

When under stress, the brain is unable to achieve homeostasis. As a result, the brain reverts to allostasis, which in turn alters the brains ability to process pleasure, which is experienced at the hedonic "set point" (see figures one).[39] Thus, previous pleasures may become no longer pleasurable. This is also known as anhedonia, or "pleasure deafness". When stressed, the addict may experience extreme craving—an intense, emotional, obsessive experience.[40]

Choice

An addict may incur damage to the orbitofrontal cortex (OFC), the anterior cingulate cortex (ACC), and the prefrontal cortex (PFC). This damage causes a tendency to choose small and immediate rewards over larger but delayed rewards, deficits in social responding due to decreased awareness of social cues, and a failure of executive function such as sensitivity to consequences.[41]

Licensed practitioners

Many degrees provide space for the treatment of addictions. The educational background that each professional obtains will contain similarities but the philosophy and the viewpoint from which the material is delivered may vary. The required amount of education prior to earning a certificate or degree also varies. A few of the more commonly recognized fields of study are included.[42]

  • Psychologist
  • Psychiatrist
  • Licensed Chemical Dependency Counselor
  • Licensed Clinical Social Worker
  • Licensed Social Worker
  • Licensed Professional Counselor
  • Paraprofessional

Recognized certifications

Many certifications are recognized in the field of addiction psychology. Each have their own requirements.

  • Certification for Alcohol and Drug Counselor Candidate.[43]
  • Credentialed Alcoholism and Substance Abuse Counselor.[43]
  • A Certified Chemical Dependency Counselor.[43]
  • Substance Abuse Counselor/Certified Addiction Counselor.[43]
  • The Certified Addiction Professional.[43]
  • Certified Addiction Treatment Counselors.[43]
  • Combined Certifications With Other Degrees.[44]

Treatment

Both process addiction and behavioral addiction have many dimensions causing disarray in many aspects of the addicts' life. Treatment programs are not a one size fits all phenomenon, hence there are different modalities or levels of care. Effective treatment programs incorporate many components to address each dimension. The addict suffers from psychological dependence and some may suffer from physical dependence.[45]

Helping an individual stop using drugs is not enough. Addiction treatment must also help the individual maintain a drug-free lifestyle, and achieve productive functioning in the family, at work, and in society. Addiction is a disease which alters the structure and function of the brain. The brain circuitry may take months or years to recover after the addict has recovered.[45]

Contingency Management can be a treatment used to treat psychoactive addictions, which aims to change behavior by incorporating positive and negative reinforcements.[46] Some common reinforcers used within contingency management are vouchers, prized-based, methadone take-home dosages, altering the dosage amount, and cash.[47] Based upon the principles of operant conditioning, contingency management treatments involve daily or frequent monitoring such as: the individual addicted to drugs providing a drug free urine sample, then receiving the incentive after showing proof of drug abstinence.[48] Therefore, within operant conditioning, continuing to receive the reward increased drug abstinence.

As an example, within prized-based contingency management, individuals with addictions earn opportunities to draw from a prize bowl each time they provide a negative drug sample, which means the more negative drug samples, the more prizes the individual can win. The prize bowl may contain rewards with slips of paper that say, "Good Job" as praise, "small= $1," "large= $20," or "jumbo= $100."[48] Contingency management has been shown to help individuals struggling with addiction reach abstinence with a wide range of addictive drugs (e.g., alcohol, opiates, cocaine, and nicotine).[48]

This may explain why drug abusers are at risk for relapse even after long periods of abstinence and despite the potentially devastating consequences. Research shows that most addicted individuals need a minimum of 3 months in treatment to significantly reduce or stop their drug use, however treatment in excess of 3 months has a greater success rate. Recovery from addiction is a longterm process.[45]

Psychedelics: A Potential Treatment to Some Drug Addictions

In recent years, researchers have tested psychedelics as a potential treatment to addiction, specifically serotonergic psychedelics. This kind of psychedelic modulates serotonin receptors and may even involve sigma-1 receptors.[49] Some examples of serotonergic psychedelics include mescaline, ayahuasca, psilocybin, and LSD, all of which have low addictive potentials, thus providing evidence that they may be a good alternative treatment drug.[50] Although the actions of these psychedelics aren't yet fully understood, some professionals hypothesize that the 5-HT2A agonism "could provoke a glutamate release leading to an activation of the fronto-cortical glutamate receptor."[51] This agonism is also linked to the psychedelic effect.[52]

In early studies exploring the effects of LSD on alcohol-use disorders, results showed that there could be a beneficial effect in treating alcohol-related addictions.[53] More recent research has shown that mice given ayahuasca were prevented from being alcohol dependent because of the treatment.[54] Also, another study showed significant decreases in the use of alcohol by alcoholics when they were treated with psilocybin.[55] In a similar study, 80% of tobacco-addicted participants given psilocybin reported tobacco abstinence after only six months.[56] Although these promising findings suggest that some psychedelics may have anti-addictive features, more research is clearly needed, especially because not everyone responds to their effects.[49]

Modalities of care

The modality or level of care needed for a patient is decided by the treating professional in conjunction with the patient when feasible. As expected, the patient receiving treatment will likely take steps forward and backward the level of care will likely to fluctuate. Common modalities are explained. For people who are in search for help, their first stop is going to be a rehabilitation center. From there, a group of LCDC (licensed chemical dependency councilors) will then help them with the base of why the person is addicted. They will then go on and continue on the path that is best for them and recovering.

Detoxification and medically managed withdrawal

The process when the body rids itself of drugs is referred to as detoxification, and is usually concurrent with the side effects of withdrawal, which vary depending on the substance(s); and are often unpleasant and even fatal. Physicians may prescribe a medication that will help decrease the withdrawal symptoms, while the addict is receiving care in an inpatient or outpatient setting. Detoxification is generally considered a precursor to or a first stage of treatment because it is designed to manage the acute and potentially dangerous physiological effects of stopping drug use.[57][58] This is generally the hardest part of getting rid of an addiction. All of the different side effect that come in this withdrawal processes is almost undoable alone.

Long-term residential

Treatment is structured and operates 24 hours a day. Residents will remain in treatment from usually 6 to 12 months while developing accountability, responsibility and socialization skills. Activities are designed to help addicts recover from destructive behavior patterns, while adopting positive behavioral patterns. Constructive methods of interacting with others and improving self-esteem are other areas of focus. The therapeutic community model is an example of one treatment approach. Many therapeutic communities provide a more comprehensive approach to include employment training and other support services.[58][59][60][61]

Short-term residential

Short-term residential programs are on average 3–6 weeks in a residential setting. The program is intensive, followed by more extended outpatient treatment to include individual and/or group therapy, 12-step Anonymous programs, or other forms of support. Because of the short duration of this modality, it is even more important for individuals to remain active in outpatient treatment programs to help decrease the risk of relapse following residential treatment.[58]

Outpatient-treatment programs

Outpatient treatment programs vary regarding the services offered and the intensity. It's more affordable and may be more suitable for patients who are employed full-time and/or who have secured multiple social supports. Outpatient programs may include group and/or individual therapy, intensive outpatient program, and partial hospitalization. Some outpatient programs are also designed to treat patients with medical or other mental health problems in addition to their drug disorders. Any kind of substance abuse eventually starts affecting multiple parts of the brain, thus leading to many mental health issues: paranoia, depression, anxiety, aggression, hallucinations, etc.[58][62] These programs offer similar treatments and care as inpatient facilities. The difference is, with this kind of program, the patients are still allowed to live at home during their recovery process. While working and/or caring for their families, they must attend scheduled treatment sessions through the program throughout the week. There is a downside to this type of program, and that is a greater risk of relapse. Unlike inpatient facilities where there are no distractions of everyday life, these patients will struggle with possible encounters of triggers that challenge their sobriety. Therefore, outpatient programs are recommended to patients who are at a mild stage of addiction and have the right mindset to wanting to reach recovery.[63]

Inpatient rehabs

Inpatient rehabs are substance-free facilities in which patients reside during their recovery process without the distractions of everyday life. Patients are required to check themselves in to overcome their addiction. These facilities are designed to focus on all aspects of each patients’ addiction. Here they will receive 24/7 medical care as well as emotional support from psychologists, counselors, and psychiatrists. The first step of treatment is medically-assisted detoxification, where the patient's vital signs are monitored while the drugs exit the system. The patient can be given necessary medicine to lessen cravings and withdrawals. Usually, these programs run anywhere from 28 days to 6 months.[63]

Individualized drug counseling

Individualized drug counseling not only focuses on reducing or stopping illicit drug or alcohol use; it also addresses related areas of impaired functioning such as employment status, illegal activity, and family/social relations as well as the content and structure of the patient's recovery program. Through its emphasis on short-term behavioral goals, individualized counseling helps the patient develop coping strategies and tools to abstain from drug use and maintain abstinence. The addiction counselor encourages 12-step participation (at least one or two times per week) and makes referrals for needed supplemental medical, psychiatric, employment, and other services.[58]

Group counseling

An outpatient treatment option facilitated by a treatment provider and used to expand on the support system the patient already has. Groups foster a non-judgmental environment allowing patients to meet and discuss difficulties and successes of their addiction while providing ongoing support that is needed to be successful with recovery.[58] This kind of group counseling is done for people with addictions in prison as well. It gives them a sense of community in a place where they would feel their lowest.

Intensive outpatient program (IOP)

As the name implies this is an outpatient treatment option designed for addicts who for various reasons do not have the opportunity to attend an inpatient treatment program, yet who otherwise would not be able to receive the level of support needed to recover from their addiction. Programs vary in duration based on the patients need; because of the lower level of support offered, IOP is frequently used as a step down approach from patients leaving inpatient treatment but who are still in need of intensive therapy.[58]

Peer recovery coaching

Peer Recovery Coaching are professionally trained and certified addiction recovery coaches that have lived experiences with substance abuse.[64] Recovery coaches work individually with the patients and serve as a guide to develop a personalized treatment plan, connect clients to other types of care if needed, create a sober support network, and use their own experiences to help clients adjust to living a sober life. While lesser known, studies have shown recovery coaching to play an important role in the addiction field for both clients and primary care physicians.[65][66]

Prevention, relapse, and recovery

Therapeutic orientations and approaches

In 1878, the Index Medicus published research conducted and written by American physician W.H. Bentley. Bentley's research described his success in treating patients addicted to the "opium habit" with cocaine. Two years later he reported success in treating both opium and alcohol abusers with cocaine.[13] Today, the swapping one addiction for another is referred to as crossover addiction.[67]

A variety of treatment approaches are utilized by health professionals in order to provide their clients the highest possible level of success to overcome their addictions. There is no one specific approach and often therapists will use multiple techniques.

Relapse

Relapse occurs when an addict is in the abstinence phase of their addiction, which is the phase in which one abstains from what they are addicted to, but then returns to their substance abuse. Even after having treatment, it is very common for addicts to relapse. Very few people manage to maintain sobriety without experiencing a relapse; it is not common for one to sustain perfect sobriety on their first attempt of abstinence.[88] However, those who experience relapse find that it can be upsetting. Because of this, it is important to understand what triggers one's relapse. Some common triggers include "working, having money available, using other drugs, hearing certain songs, isolation, being around other drug-using friends, and even particular days of the week."[88] Some other risk factors that may cause one to be more vulnerable to relapse include an unhealthy relationship, anxiety, depression, abuse of any kind, and other forms of trauma.[88] Triggers and other risk factors often accompany the intense physical cravings one may experience when trying to recover from an addiction, so it is important to understand what these triggers and risks are for a specific individual.[88]

Addiction recovery is a long process and relapse is likely to occur during this process.[89] Relapse can occur at any time during the recovery process, so recognizing the warning signs of relapse is important. Some of these warning signs in the recovering individual may include increased use of other drugs (eg. nicotine or caffeine), isolation, feelings of depression, skipping recovery support activities, disturbed sleep, increased compulsive behaviors, avoidance when confronted, and idealized thoughts about their addiction and its associated consequences.[89] If any of these warning signs are identified, intervening with the individual may be necessary to ensure continued improvement.

Because drug addiction is considered to be a chronic illness, professionals consider it to have no cure, especially because many addicts experience relapse.[88] Despite this, drug addiction can be treated.

See also

References
  1. "Addiction Statistics - 2021". The Edge Treatment Center. Retrieved 2021-10-09.
  2. "Addiction". Psychology Today. Retrieved 3 May 2023.
  3. "ASAM Definition of Addiction". www.asam.org. Retrieved 2021-09-18.
  4. "The Psychology Behind Addiction". Desert Hope. Retrieved 2022-02-17.
  5. Miller NS, Giannini AJ (1990-01-01). "The disease model of addiction: a biopsychiatrist's view". Journal of Psychoactive Drugs. 22 (1): 83–85. doi:10.1080/02791072.1990.10472201. PMID 2324867.
  6. Heyman GM (2013). "Addiction and choice: theory and new data". Frontiers in Psychiatry. 4: 31. doi:10.3389/fpsyt.2013.00031. PMC 3644798. PMID 23653607.
  7. Olds J, Milner P (1954). "Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain". Journal of Comparative and Physiological Psychology. 47 (6): 419–427. doi:10.1037/h0058775. PMID 13233369.
  8. "Substance Abuse: Know the Signs". WebMD. Retrieved 2021-07-03.
  9. "What Is Process Addiction & Types of Addictive Behaviors?". American Addiction Centers. February 8, 2021. Retrieved 2021-07-03.
  10. Foddy B, Savulescu J (March 2010). "A Liberal Account of Addiction". Philosophy, Psychiatry, & Psychology. 17 (1): 1–22. doi:10.1353/ppp.0.0282. PMC 3959650. PMID 24659901.
  11. "addiction | Origin and meaning of addiction by Online Etymology Dictionary". www.etymonline.com. Retrieved 2021-07-03.
  12. "The Evolution of Addiction and Treatment Through the Ages". Destination Hope Substance Abuse Treatment. 15 September 2016. Retrieved 2021-07-03.
  13. Markel H (July 2011). An Anatomy of Addiction. New York: Panthean. pp. 6–8, 31, 76. ISBN 978-1-4000-7879-0.
  14. Valjak D (2017-01-16). "Sigmund Freud recommended cocaine for treatment of many physical and mental issues". The Vintage News. Retrieved 2021-07-03.
  15. About.com. "Sigmun Freud". About.com. Archived from the original on 19 November 2012. Retrieved 3 November 2012.
  16. Furnham, Adrian. "Psychosexual Stages: Freud's Theory of Personality", Psychology Today
  17. Rankin JS (March 2006). "William Stewart Halsted: a lecture by Dr. Peter D. Olch". Annals of Surgery. 243 (3): 418–425. doi:10.1097/01.sla.0000201546.94163.00. PMC 1448951. PMID 16495709.
  18. American Civil Liberties Union of Washington State (6 April 2011). "Remembering G. Alan Marlatt-Harm Reduction Pioneer". American Civil Liberties Union of Washington State. Retrieved 3 November 2012.
  19. Szalavitz M (March 2011). "Appreciation: G. Alan Marlatt Brought Compassion to Addiction Treatment". Time. Retrieved 3 November 2012.
  20. Hevesi D (21 March 2011). "G. A. Marlatt, Advocate of Shift in Treating Addicts, Dies at 69". The New York Times. Retrieved 3 November 2012.
  21. United States Senate Committee on the Judiciary. "Deputy Director of National Drug Control Policy - A. Thomas McLellan". United States Senate Committee on the Judiciary. Archived from the original on 11 November 2012. Retrieved 3 November 2012.
  22. "Arnold M. Washton". Harper Collins. Archived from the original on 30 March 2013. Retrieved 10 November 2012.
  23. William L. White
  24. White W. "Brief Professional Biography | Biographical Info | William L. White". williamwhitepapers.com. Retrieved 2016-10-20.
  25. "Addiction Society of Addiction Medicine". Addiction Society of Addiction Medicine. Retrieved September 13, 2011.
  26. "Psychology Today". Psychology Today. Retrieved September 14, 2011.
  27. O'Day D. "Can you Become Addicted to Drugs After the First Time Using?". Retrieved 2021-07-03.
  28. National Institute of Drug Abuse (2009) [1st edition 1999]. Principles of Drug Addiction Treatment: A research based guide (Second ed.). National Institute of Drug Abuse, NIH PUB #09-4180.
  29. Finney L (2018-04-30). "Tolerance and its Role In Addiction". Silvermist. Retrieved 2021-07-03.
  30. American Psychological Association. "American Psychological Association". American Psychological Association. Retrieved 15 September 2012.
  31. Society of Addiction Psychology Division 50. "Society of Addiction Psychology Division 50". Society of Addiction Psychology Division 50. Retrieved 15 September 2012.
  32. Psychopharmacology and Substance Abuse Division 28. "Psychopharmacology and Substance Abuse Division 28". Psychopharmacology and Substance Abuse Division 28. Retrieved 15 September 2012.
  33. "Society of Addiction Psychology | Society of Addiction Psychology". addictionpsychology.org. Retrieved 2021-03-09.
  34. Berridge KC, Robinson TE (December 1998). "What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?". Brain Research Reviews. 28 (3): 309–369. doi:10.1016/S0165-0173(98)00019-8. PMID 9858756. S2CID 11959878.
  35. Hancock DB, Markunas CA, Bierut LJ, Johnson EO (March 2018). "Human Genetics of Addiction: New Insights and Future Directions". Current Psychiatry Reports. 20 (2): 8. doi:10.1007/s11920-018-0873-3. PMC 5983372. PMID 29504045.
  36. Mayfield RD, Harris RA, Schuckit MA (May 2008). "Genetic factors influencing alcohol dependence". British Journal of Pharmacology. 154 (2): 275–287. doi:10.1038/bjp.2008.88. PMC 2442454. PMID 18362899.
  37. Feltenstein MW, See RE (May 2008). "The neurocircuitry of addiction: an overview". British Journal of Pharmacology. 154 (2): 261–274. doi:10.1038/bjp.2008.51. PMC 2442446. PMID 18311189.
  38. Hyman SE, Malenka RC, Nestler EJ (2006). "Neural mechanisms of addiction: the role of reward-related learning and memory". Annual Review of Neuroscience. 29: 565–598. doi:10.1146/annurev.neuro.29.051605.113009. PMID 16776597.
  39. Koob GF, Le Moal M (February 2001). "Drug addiction, dysregulation of reward, and allostasis". Neuropsychopharmacology. 24 (2): 97–129. doi:10.1016/S0893-133X(00)00195-0. PMID 11120394. S2CID 3993014.
  40. Clegg J, McCauley K (2010). Pleasure Unwoven (CD). The Institute For Addiction Study. p. 4.
  41. Kalivas PW, Volkow ND (August 2005). "The neural basis of addiction: a pathology of motivation and choice". The American Journal of Psychiatry. 162 (8): 1403–1413. doi:10.1176/appi.ajp.162.8.1403. PMID 16055761.
  42. British Psychological Society. "Types of Psychologists-'Related Fields'". British Psychological Society. Retrieved 24 October 2012.
  43. "Psychology Today Therapy Directory". Psychology Today. Archived from the original on 16 January 2008. Retrieved 16 September 2012.
  44. "Jeremy Frank Ph.D., Philadelphia Psychologist - Addiction Counselor". Retrieved 19 April 2013.
  45. National Institute on Drug Abuse (1999). Principles of Drug Addiction Treatment. National Institute on Drug Abuse.
  46. Prendergast M, Podus D, Finney J, Greenwell L, Roll J (November 2006). "Contingency management for treatment of substance use disorders: a meta-analysis". Addiction. 101 (11): 1546–1560. doi:10.1111/j.1360-0443.2006.01581.x. PMID 17034434.
  47. Prendergast M, Podus D, Finney J, Greenwell L, Roll J (2006). "Contingency management for treatment of substance use disorders: a meta-analysis". Addiction. Centre for Reviews and Dissemination (UK). 101 (11): 1546–1560. doi:10.1111/j.1360-0443.2006.01581.x. PMID 17034434.
  48. Benishek LA, Dugosh KL, Kirby KC, Matejkowski J, Clements NT, Seymour BL, Festinger DS (September 2014). "Prize-based contingency management for the treatment of substance abusers: a meta-analysis". Addiction. 109 (9): 1426–1436. doi:10.1111/add.12589. PMC 4203362. PMID 24750232.
  49. Tófoli LF, de Araujo DB (2016-01-01). Zahr NM, Peterson ET (eds.). "Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics". International Review of Neurobiology. Imaging the Addicted Brain. Academic Press. 129: 157–185. doi:10.1016/bs.irn.2016.06.005. PMID 27503452.
  50. Shmulewitz D, Greene ER, Hasin D (October 2015). "Commonalities and Differences Across Substance Use Disorders: Phenomenological and Epidemiological Aspects". Alcoholism: Clinical and Experimental Research. 39 (10): 1878–1900. doi:10.1111/acer.12838. PMC 5096462. PMID 26332166.
  51. Romeo B, Hermand M, Pétillion A, Karila L, Benyamina A (May 2021). "Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review". Journal of Psychiatric Research. 137: 273–282. doi:10.1016/j.jpsychires.2021.03.002. PMID 33730602. S2CID 232299763.
  52. Madsen MK, Fisher PM, Burmester D, Dyssegaard A, Stenbæk DS, Kristiansen S, et al. (June 2019). "Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels". Neuropsychopharmacology. 44 (7): 1336–1337. doi:10.1038/s41386-019-0360-5. PMC 6784978. PMID 30846853.
  53. Krebs TS, Johansen PØ (July 2012). "Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials". Journal of Psychopharmacology. 26 (7): 994–1002. doi:10.1177/0269881112439253. PMID 22406913. S2CID 10677273.
  54. Oliveira-Lima AJ, Santos R, Hollais AW, Gerardi-Junior CA, Baldaia MA, Wuo-Silva R, et al. (April 2015). "Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice". Physiology & Behavior. 142: 28–36. doi:10.1016/j.physbeh.2015.01.032. PMID 25637859. S2CID 2340314.
  55. Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ (March 2015). "Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study". Journal of Psychopharmacology. 29 (3): 289–299. doi:10.1177/0269881114565144. PMID 25586396. S2CID 6519317.
  56. Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR (November 2014). "Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction". Journal of Psychopharmacology. 28 (11): 983–992. doi:10.1177/0269881114548296. PMC 4286320. PMID 25213996.
  57. Kleber HD (1996). "Outpatient detoxification from opiates". Primary Psychiatry. 1: 42–52.
  58. National Institute on Drug Abuse (April 2009). Principles of Drug Addiction Treatment: A Research Based Guide, Pub number 09-4180 (Second ed.). Diane Publishing. Archived from the original on 2013-01-08. Retrieved 2012-11-20.
  59. Tims FM, Jainchill N, De Leon G (1994). "Therapeutic communities and treatment research". NIDA Research Monograph. 144 (144): 1–15. PMID 8742603. NIH Pub No. 94-3633. Archived from the original on 12 January 2014. Retrieved 14 November 2012.
  60. Inciardi JA, Tims FM, Fletcher BW, eds. (1993). Innovative Approaches in the Treatment of Drug Abuse: Program Models and Strategies. Westport, CT: Greenwood Press. pp. 45–60.
  61. Sacks S, Banks S, McKendrick K, Sacks JY (January 2008). "Modified therapeutic community for co-occurring disorders: a summary of four studies". Journal of Substance Abuse Treatment. 34 (1): 112–122. doi:10.1016/j.jsat.2007.02.008. PMC 2572263. PMID 17574792.
  62. McLellan AT, Grissom GR, Brill P, Durell J, Metzger DS, O'Brien CP (1993). "Private substance abuse treatments: are some programs more effective than others?". Journal of Substance Abuse Treatment. 10 (3): 243–254. doi:10.1016/0740-5472(93)90071-9. PMID 8391086.
  63. "Treatment". Addiction Center. Retrieved 2022-03-09.
  64. Satinsky EN, Doran K, Felton JW, Kleinman M, Dean D, Magidson JF (January 31, 2020). "Adapting a peer recovery coach-delivered behavioral activation intervention for problematic substance use in a medically underserved community in Baltimore City". PLOS ONE. 15 (1): e0228084. Bibcode:2020PLoSO..1528084S. doi:10.1371/journal.pone.0228084. PMC 6993963. PMID 32004328.
  65. Jack HE, Oller D, Kelly J, Magidson JF, Wakeman SE (2018-07-03). "Addressing substance use disorder in primary care: The role, integration, and impact of recovery coaches". Substance Abuse. 39 (3): 307–314. doi:10.1080/08897077.2017.1389802. PMID 28991516. S2CID 205602994.
  66. Szydlowski SJ, Amato PP (December 2015). "The Role of the Recovery Coach". Journal of Management Policies and Practices. 3 (2): Abstract 2. doi:10.15640/jmpp.v3n2a2. Retrieved 2022-11-03.
  67. "The Addictive Process". Psychiatry and Wellness. Behavioral Medicine Associates. Retrieved 24 October 2012.
  68. Cherry K. "The Rise of Behaviorism". About.com. Archived from the original on 19 November 2012. Retrieved 10 November 2012.
  69. Watson JB (1998). Behaviorism (7th printing ed.). New Brunswick, NJ: Transaction Publishers. pp. 11, 16. ISBN 978-1-56000-994-8.
  70. Cain DJ (February 2010). Person Centered Psychotherapies. ISBN 978-1433807213.
  71. Yontef GM (1993). Awareness, Dialogue, and Process. Maine: The Gestalt Journal Press. ISBN 978-0939266203.
  72. Beck J (2011). Cognitive Behavioral Therapy: Basics and Beyond (Second ed.). New York: Guilford Press. pp. 2–10. ISBN 978-1-60918-506-0.
  73. Mayo Clinic staff. "Cognitive Behavioral Therapy". Mayo Clinic. Retrieved 3 October 2012.
  74. "Cognitive Behavioral Therapy". National Association of Cognitive- Behavioral Threrapists. Retrieved 3 October 2012.
  75. Hartney E (3 March 2011). "Cognitive Behavioral Therapy for Addictions". About.com. Archived from the original on 18 November 2012. Retrieved 10 November 2012.
  76. Pederson L, Sidwell CP (2012). The Expanded Dialectical Behavior Therapy Skills Training Manual. Wisconsin: Premier Publishing and Media. ISBN 978-1-936128-12-9.
  77. Haggerty J. "Psychodynamic Therapy". Psych Central. Retrieved 30 September 2012.
  78. "International Expressive Arts Therapy Association". International Expressive Arts Therapy Association. Archived from the original on 7 June 2012. Retrieved 30 September 2012.
  79. "What is Integrative Psychotherapy". International Integrative Psychotherapy Association. Retrieved 6 October 2012.
  80. Frank J. "Harm Reduction". Retrieved 5 October 2012.
  81. Marlatt AG, Larimer ME (2012). Marlatt AG (ed.). Harm Reduction: Pragmatic Strategies for Managing High Risk Behaviors (Second ed.). New York, New York: The Guilford Press. pp. 147–48, 151. ISBN 978-1-4625-0256-1.
  82. "What is Harm Reduction?". Harm Reduction International. Retrieved 5 October 2012.
  83. Marlatt GA (November–December 1996). "Harm reduction: come as you are". Addictive Behaviors. 21 (6): 779–788. doi:10.1016/0306-4603(96)00042-1. PMID 8904943.
  84. Marlatt GA, Tapert SF (1993). Harm reduction: Reducing the risks of addictive behaviors. CA: Sage Publications. pp. 243–273.
  85. "Types of Therapies". CRC Health Group. Retrieved 30 September 2012.
  86. Kosmulski M (April 2010). "Skeptical comment about double-blind trials". Journal of Alternative and Complementary Medicine. 16 (4): 339. doi:10.1089/act.2010.16603. PMID 20374096.
  87. "Animal Assisted Therapy and Addiction". Passages Malibu. 2011-06-05. Retrieved 5 October 2012.
  88. Snow D, Gorman M (July 1999). "Working with relapse". The American Journal of Nursing. 99 (7): 69. doi:10.1097/00000446-199907000-00045. PMID 10410137.
  89. Sweeney MJ, Chadwick MC. "What to Expect in Treatment. GPSolo". GPSolo. 23 (7): 26–30. ISSN 1528-638X. JSTOR 23673295.

Further reading
  • Gerstein DR, Harwood HJ, eds. (1990). Treating Drug Problems. Washington, D.C.: National Academy Press. ISBN 978-0-309-04285-7.
  • Gilbert M, Orlans V (2010). Integrative Therapy: 100 Key Points and Techniques. Routledge. ISBN 978-1-136-87682-0.
  • Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM (December 1997). "Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS)". Psychology of Addictive Behaviors. 11 (4): 291–298. doi:10.1037/0893-164X.11.4.261.
  • Miller MM (1998). "Traditional approaches to the treatment of addiction.". In Graham AW, Schultz TK (eds.). Principles of addiction medicine (Second ed.). Washington, D.C.: American Society of Addiction Medicine.
  • Simpson DD, Joe GW, Brown BS (December 1997). "Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS)". Psychology of Addictive Behaviors. 11 (4): 294–307. doi:10.1037/0893-164X.11.4.294.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.